Koos doesn't need a rabbit this week. Wednesday is C. Ichim's abstract presentation from 8 AM - 12 PM and she is supposed to reveal new milestone achievements relating to the targeting of NR2F6 or NR2F2 and cancer stem cell differentiation.
This should be accompanied by a PR the morning of Wed I would expect, or Thursday morning at the latest. We know this news should be significant and we hope it will generate more interest all around in the research being conducted by RGBP, especially in light of the IP now held.
The article from Nano news site is something we already know - that Koos, by himself, is not effective and has not been able to produce according to schedules released.
What has changed is that 2 scientists have handed over their life research to RGBP and committed themselves to acheiving significant milestones and development, including new INDs by the middle of 2016. That's no small commitment and 2015 is full of new hope in spite of the past ineffectiveness of Koos in 2013-2014.
Market Data 
Markets 
AI
